Mechanistically, METTL3 impedes tumor progression through m6A modification on NF-κB mRNA in a YTHDF2-dependent manner, which in turn attenuates IL-8 production of papillary TC cells to recruit neutrophils, ultimately suppressing tumor progression [52]. Here, YTHDF2 is linked to neoplasm.